-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Emmaus Life Sciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q2 2025.
- Emmaus Life Sciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 63.9M shares, a 0.81% increase year-over-year.
- Emmaus Life Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 63.2M shares, a 19.1% increase from 2023.
- Emmaus Life Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 53.1M shares, a 7.41% increase from 2022.
- Emmaus Life Sciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 49.4M shares, a 0.38% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)